Followers | 919 |
Posts | 23472 |
Boards Moderated | 1 |
Alias Born | 12/13/2007 |

Tuesday, May 09, 2023 8:11:47 PM
Bonzaii skippyies

Recent SMMT News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/20/2025 09:07:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/17/2025 08:13:55 PM
- Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 06/06/2025 08:44:00 PM
- Summit Therapeutics to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference • Business Wire • 06/05/2025 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/30/2025 08:17:49 PM
- Summit Therapeutics Shares Slip Following Mixed Results from Lung Cancer Trial • IH Market News • 05/30/2025 12:35:33 PM
- Ivonescimab Plus Chemotherapy Demonstrates Statistically Significant and Clinically Meaningful Improvement in Progression-Free Survival in Patients with EGFR-Mutant Non-Small Cell Lung Cancer after EGFR TKI Therapy in Global Study • Business Wire • 05/30/2025 10:00:00 AM
- Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 05/16/2025 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/01/2025 10:17:22 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/01/2025 08:11:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/01/2025 08:10:10 PM
- Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2025 • Business Wire • 05/01/2025 08:09:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/29/2025 08:51:12 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/29/2025 08:44:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/25/2025 08:38:11 PM
- Interim Overall Survival Analysis Requested from Chinese Health Authorities Shows a Clinically Meaningful, Positive Trend Favoring Ivonescimab Compared to Pembrolizumab in PD-L1 Positive Advanced NSCLC from HARMONi-2 Study Conducted by Akeso in China • Business Wire • 04/25/2025 06:50:00 PM
- Summit Therapeutics to Host First Quarter 2025 Financial Results & Operational Progress Call on May 1, 2025 • Business Wire • 04/24/2025 08:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/23/2025 12:54:14 PM
- Ivonescimab in Combination with Chemotherapy Achieves Statistically Significant Superiority in PFS vs. Tislelizumab (PD-1 Inhibitor) Plus Chemotherapy in 1L Treatment of Patients with Squamous NSCLC in HARMONi-6 Study Conducted by Akeso in China • Business Wire • 04/23/2025 10:15:00 AM
- Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 04/04/2025 08:15:00 PM
- Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 03/21/2025 08:15:00 PM
- Robert LaCaze, Innovative Growth-Driver in Oncology, Joins Summit Therapeutics as Chief Commercial Officer • Business Wire • 03/17/2025 08:24:00 PM
- Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 03/14/2025 08:15:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/24/2025 11:53:28 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/24/2025 11:08:58 AM
Authentic Holdings Inc. Partnership with Swerve TV Debuts with Highly Successful 'Ring of Combat' Live Broadcast • AHRO • Jun 18, 2025 12:45 PM
ePIC Blockchain Signs LOI with A.R.T. Digital to Redefine Bitcoin Miner Design with Breakthrough Air-Cooling Technology • CGAC • Jun 18, 2025 12:41 PM
Avant Technologies' JV Partner, Ainnova, Begins Diabetic Retinopathy Screenings with Leading Pharmacies • AVAI • Jun 17, 2025 8:00 AM
Cannabix Technologies Receives Notice of Allowance from USPTO for Contactless Breath Analysis • BLO • Jun 17, 2025 8:00 AM
A.R.T. Digital Holdings (OTC: CGAC) Secures Non-Dilutive Financing for George West Site Supporting NASDAQ: BTBT • CGAC • Jun 17, 2025 5:07 AM
VAYK to Acquire Up to $9 million in Time-share Vacation Properties Through Non-Cash Deals • VAYK • Jun 11, 2025 9:45 AM